- Manipal Health Enterprises Ltd opened its IPO today, targeting to raise up to ₹9,275 crore with a price band of ₹560-590 per share.
- The IPO consists of a fresh issue of ₹8,000 crore and an offer for sale of up to 2.16 crore shares.
- Subscription for the IPO will close on July 31, 2026.
- Ahead of the IPO, the company has raised ₹4,167 crore from anchor investors, including major global institutions.
- The company plans to utilize ₹5,378 crore from the fresh issue proceeds for debt repayment of its subsidiary, Manipal Hospitals Pvt. Ltd.
- The IPO is expected to attract significant interest due to the company's position as one of India's largest healthcare providers, operating 49 hospitals and 13,037 licensed beds across the country.
- The company reported a 26% year-on-year increase in total income for FY26, amounting to ₹10,520.5 crore.
Manipal Health Enterprises Ltd's IPO, which opened today, aims to raise ₹9,275 crore, with a price band of ₹560-590 per share.1

The offering consists of a fresh issue of ₹8,000 crore and an offer for sale of 2.16 crore shares.2

The company has allocated 75% of the issue for qualified institutional buyers (QIBs), 15% for non-institutional investors (NIIs), and 10% for retail investors.

"We believe that the IPO is fully priced and recommend a 'Subscribe Long Term' rating to the IPO," stated a market analyst.
The IPO has already attracted ₹4,167 crore from anchor investors, including major global players like Abu Dhabi Investment Authority and Goldman Sachs.4

The proceeds from the fresh issue will primarily be used to repay borrowings of its subsidiary, Manipal Hospitals Pvt. Ltd., which reported a revenue of ₹10,520.5 crore for FY26.7

The company operates 49 hospitals and has a strong presence in India's healthcare sector, which is projected to grow at a CAGR of 10-12% until FY30.6

The IPO closes on July 31, with shares expected to list on August 5, 2026.

"Despite being one of India's largest healthcare IPOs, the grey market premium indicates muted listing expectations," noted market observers, with a current GMP of ₹10.
“The IPO includes a fresh issue of ₹8,000 crore and an offer for sale of ₹1,275 crore, with 75% reserved for qualified institutional buyers. The company aims to use ₹5,378 crore from the fresh issue to repay borrowings of its subsidiary, Manipal Hospitals Pvt. Ltd.”